GENE ONLINE|News &
Opinion
Blog

M&A
M&A Gene Therapy
Charles River Labs Expands Manufacturing Capabilities Through CDMO Acquisition
2021-02-23
M&A Rare Disease
Horizon Buys AstraZeneca Spinout for $3 Billion to Broaden Rare Disease Pipeline
2021-02-02
COVID-19
Thermo Fisher Expands Portfolio by Acquiring COVID-19 Diagnostic Company
2021-01-20
M&A AAV
Thermo Fischer Snags Novasep’s Low-Cost CMO for $879 Million
2021-01-17
M&A Immuno-oncology
Sanofi Looks to Bolster Immunology Pipeline By Acquiring Kymab for $1.5 Billion
2021-01-13
M&A Anti-seizure
Angelini Aims for CNS Dominance with Arvelle Therapeutics Acquisition
2021-01-10
Special COVID-19
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
China’s Hasten Biopharmaceutic Acquires Five Non-Core Assets from Japan’s Takeda
2020-12-24
M&A
Servier Aims to Expand Portfolio for Hematological Cancers by Acquiring Agios
2020-12-23
M&A Neuroscience
Novartis Looks to Diversify Neuroscience Pipeline with $770 Million Worth Acquisition
2020-12-22
Startups lipid production
Ginkgo Acquires Bioengineering Assets of Massachusetts-Based Biotech Startup
2020-12-20
Gene Editing
Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
2020-12-17
M&A Gene Therapy
Why is Eli Lilly Seeking Prevail’s Gene Therapy Pipeline?
2020-12-17
M&A iADC platform
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
M&A Hepatitis Delta Virus
Hoping to Boost Revenue Growth, Gilead Acquires MYR in a $1.4 B Deal
2020-12-13
1 … 9 10 11 12 13 14
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top